Cases of pediatric B/myeloid MPAL with expression of MPO and CD15, CD33, or CD13 with B-ALL related cytogenetics as ETV6-RUNX1, and trisomy 10 and 4, seem to do well with an ALL-type regimen [25]. Here, CD33 is linked to mixed phenotype acute leukemia.